You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

RAD51C mutation

Showing 26 - 50 of 3,061
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Acute Myeloid Leukemia, Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome, Atypical Chronic Myeloid

Active, not recruiting
  • Acute Myeloid Leukemia
  • +9 more
  • Los Angeles, California
  • +5 more
Jan 27, 2023

Ovarian Cancer Trial in Pittsburgh (Olaparib tablet)

Not yet recruiting
  • Ovarian Cancer
  • Olaparib tablet
  • Pittsburgh, Pennsylvania
    UPMC Hillman Cancer Center
Nov 1, 2023

Anatomic Stage III Breast Cancer AJCC v8, Anatomic Stage IV Breast Cancer AJCC v8, Metastatic HER2-Negative Breast Carcinoma

Not yet recruiting
  • Anatomic Stage III Breast Cancer AJCC v8
  • +3 more
  • (no location specified)
Jul 28, 2023

Malignant Solid Tumors Trial in France (Nilotinib (400 mg BID), Everolimus (10 mg QD), Sorafenib (400 mg BID))

Recruiting
  • Malignant Solid Neoplasms
  • Nilotinib (400 mg BID)
  • +6 more
  • Bordeaux, France
  • +6 more
Dec 15, 2022

Triple Negative Breast Cancer, Breast Cancer Trial in Stanford (Capecitabine)

Recruiting
  • Triple Negative Breast Cancer
  • Breast Cancer
  • Stanford, California
    Stanford University
Jan 7, 2022

Metastatic Castration Resistant Prostate Cancer Trial in Worldwide (Rucaparib)

Completed
Has Results
  • Metastatic Castration Resistant Prostate Cancer
  • Birmingham, Alabama
  • +148 more
Jun 14, 2022

Metastatic Pancreatic Cancer Trial in Barcelona, La Coruña, Santander (olaparib+durvalumab)

Recruiting
  • Metastatic Pancreatic Cancer
  • Barcelona, Spain
  • +2 more
Dec 29, 2022

Advanced Solid Malignancies Trial in Worldwide (AZD9574, Temozolomide)

Recruiting
  • Advanced Solid Malignancies
  • La Jolla, California
  • +30 more
Dec 20, 2022

Advanced Breast Cancer Trial in Seoul (Talazoparib Oral Capsule)

Recruiting
  • Advanced Breast Cancer
  • Talazoparib Oral Capsule
  • Seoul, Korea, Republic of
    Seoul National University Hospital
May 14, 2021

HER2, Colorectal Cancer Trial (Disitamab Vedotin Combined With Fruquintinib)

Not yet recruiting
  • HER2
  • Colorectal Cancer
  • Disitamab Vedotin Combined With Fruquintinib
  • (no location specified)
Dec 21, 2022

Locally Advanced Pancreatic Adenocarcinoma, Metastatic Pancreatic Adenocarcinoma, Recurrent Pancreatic Carcinoma Trial in

Active, not recruiting
  • Locally Advanced Pancreatic Adenocarcinoma
  • +4 more
  • Biopsy
  • +4 more
  • Chicago, Illinois
  • +11 more
Jun 28, 2022

Solid Tumor, Adult, Homologous Recombination Deficiency Trial in Washington, Hackensack, Charlotte (Niraparib, Carboplatin)

Recruiting
  • Solid Tumor, Adult
  • Homologous Recombination Deficiency
  • Washington, District of Columbia
  • +2 more
Aug 31, 2021

Malignant Melanoma, BRAF V600 Mutation, Brain Metastases Trial in France (Stereotaxic radiosurgery (SRS), Binimetinib Oral

Recruiting
  • Malignant Melanoma
  • +2 more
  • Stereotaxic radiosurgery (SRS)
  • +3 more
  • Bobigny, France
  • +20 more
Oct 7, 2022

Waldenström's Macroglobulinemia Trial in Worldwide (BGB-3111, Ibrutinib)

Completed
  • Waldenström's Macroglobulinemia
  • Phoenix, Arizona
  • +79 more
Jul 6, 2022

Advanced (Stage IIIB-C-IV) Ovarian, Primary Peritoneal and Fallopian Tube Cancer Trial in Italy (Carboplatin, Paclitaxel,

Recruiting
  • Advanced (Stage IIIB-C-IV) Ovarian, Primary Peritoneal and Fallopian Tube Cancer
  • Legnago, Italy
  • +6 more
Aug 24, 2021

Pancreatic Cancer Genetics

Recruiting
  • Pancreatic Cancer
    • New York, New York
      Columbia University Medical Center
    Aug 13, 2021

    STXBP1 Encephalopathy With Epilepsy, SLC6A1 Neurodevelopmental Disorder Trial in Aurora, New York (Glycerol Phenylbutyrate 1100

    Active, not recruiting
    • STXBP1 Encephalopathy With Epilepsy, SLC6A1 Neurodevelopmental Disorder
    • Glycerol Phenylbutyrate 1100 MG/ML [Ravicti]
    • Aurora, Colorado
    • +1 more
    Jan 24, 2023

    Amyotrophic Lateral Sclerosis Associated With a SOD1 Gene Mutation Trial in Worldwide (BIIB067 (Tofersen), Placebo)

    Recruiting
    • Amyotrophic Lateral Sclerosis Associated With a SOD1 Gene Mutation
    • BIIB067 (Tofersen)
    • Placebo
    • Scottsdale, Arizona
    • +28 more
    Oct 27, 2022

    Slow-Flow Vascular Malformation, Fast-Flow Vascular Malformation, Vascular Malformations Trial in Parkville (Alpelisib,

    Not yet recruiting
    • Slow-Flow Vascular Malformation
    • +17 more
    • Parkville, Victoria, Australia
      The Royal Children's Hospital
    Aug 7, 2023

    Ischemic Stroke, Transient Ischemic Attack Trial in Singapore (Genetic testing)

    Not yet recruiting
    • Ischemic Stroke
    • Transient Ischemic Attack
    • Genetic testing
    • Singapore, Singapore
      Singapore General Hospital
    Mar 9, 2023

    Ovarian Cancer Trial in Manchester (Olaparib, Cediranib, Platinum-based Chemotherapy)

    Completed
    • Ovarian Cancer
    • Manchester, United Kingdom
      The Christie NHS Foundation Trust
    Feb 4, 2022

    Alzheimers Disease, Dementia, Alzheimers Disease, Familial Trial in Worldwide (Gantenerumab, Solanezumab, Matching Placebo

    Completed
    Has Results
    • Alzheimers Disease
    • +2 more
    • Birmingham, Alabama
    • +24 more
    Aug 25, 2022

    Gene Mutation-Related Cancer, Genetic Predisposition Trial in Worldwide (salivary kit)

    Recruiting
    • Gene Mutation-Related Cancer
    • Genetic Predisposition
    • salivary kit
    • Saint-Cloud, Haut De Seine, France
    • +56 more
    Aug 2, 2021

    Lymphoma, Non-Hodgkin, Multiple Myeloma, Advanced Solid Tumors Trial in United States (Crizotinib, Palbociclib, Sunitinib)

    Recruiting
    • Lymphoma, Non-Hodgkin
    • +2 more
    • Birmingham, Alabama
    • +125 more
    Nov 21, 2022

    The Prevelence of HBB c.93-21 G-A in ß Thalassemia Patients

    Recruiting
    • Beta-Thalassemia
    • ARMS PCR
    • Assiut, Egypt
      Faculty of Medicine Assiut University
    Jan 30, 2023